Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
50%
Ph phase_1
3
50%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(5)

Detailed Status

Completed5
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 13 (50.0%)
N/A3 (50.0%)

Trials by Status

completed583%
recruiting117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
OTHER
Total Trials
6